Literature DB >> 15796197

Herpes simplex virus as a determinant risk factor for coronary artery atherosclerosis and myocardial infarction.

Dimosthenis Kotronias1, Nikiforos Kapranos.   

Abstract

BACKGROUND: Viruses have been detected in atherosclerotic and non-atherosclerotic vascular tissues and may be involved in the mechanisms of atherogenesis. In the present study, we investigated the role of herpes simplex virus (HSV) in the early and late stages of coronary artery atherosclerosis. METHODS AND
RESULTS: HSV prevalence was investigated in coronary artery samples from 42 autopsy cases, in which death was related to myocardial infarction (MI), and 28 young age autopsy cases without heart disease, who had died from fatal injuries (young victim group), using nested polymerase chain reaction (nPCR) and the highly sensitive in situ hybridization with tyramide signal amplification (ISH-TSA). HSV was detected by nPCR in 18 out of 42 (43%) myocardial infarction cases and in 7 out of 28 (25%) young victim group cases, respectively. Using ISH-TSA, HSV DNA was detected in the coronary arteries of the MI group in 16 out of 42 (38%) of the cases; the hybridization signal was localized in the nuclei of endothelial cells, the nuclei of smooth muscle cells, the macrophages around the atheroma, and in the lymphocytes infiltrating the vascular wall. In the young victim group, HSV DNA was detected by ISH-TSA in 7 out of 28 (25%) autopsy cases; the signal was localized in the endothelial and the intimal spindle cells of the coronary arteries.
CONCLUSION: The findings of this study suggest that HSV seems to play a significant role in the initiation and progression of coronary atherosclerosis, and may open new perspectives in preventing the development of vascular damage via an appropriate antiviral treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15796197

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  7 in total

Review 1.  In-house nucleic acid amplification assays in research: how much quality control is needed before one can rely upon the results?

Authors:  Petra Apfalter; Udo Reischl; Margaret R Hammerschlag
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 2.  The role of nutrition and nutraceutical supplements in the treatment of hypertension.

Authors:  Mark Houston
Journal:  World J Cardiol       Date:  2014-02-26

Review 3.  Viral infection and atherosclerosis.

Authors:  Nima Hemmat; Amin Ebadi; Reza Badalzadeh; Mohammad Yousef Memar; Hossein Bannazadeh Baghi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-05       Impact factor: 3.267

Review 4.  Nutrition and nutraceutical supplements for the treatment of hypertension: part I.

Authors:  Mark Houston
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-08-19       Impact factor: 3.738

5.  Vascular Aging and COVID-19.

Authors:  Ignas Badaras; Agnė Laučytė-Cibulskienė
Journal:  Angiology       Date:  2022-08-28       Impact factor: 3.299

Review 6.  Antigen-induced immunomodulation in the pathogenesis of atherosclerosis.

Authors:  Natalia Milioti; Alexandra Bermudez-Fajardo; Manuel L Penichet; Ernesto Oviedo-Orta
Journal:  Clin Dev Immunol       Date:  2008

7.  Herpes Simplex Virus Type 1 and Type 2 Infection Increases Atherosclerosis Risk: Evidence Based on a Meta-Analysis.

Authors:  Yu Peng Wu; Dan Dan Sun; Yun Wang; Wen Liu; Jun Yang
Journal:  Biomed Res Int       Date:  2016-04-19       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.